Lapis Lazuli Pharma Enterprises Private Limited
About Lapis Lazuli Pharma Enterprises Private Limited
Data last updated:
Lapis Lazuli Pharma Enterprises Private Limited was a private limited company based in Raipur, Chhattisgarh, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the wholesale trading and distribution segment of the trading and commerce sector. It was incorporated on 16 February 2016.
The company was registered with the Registrar of Companies (ROC), Chhattisgarh, under CIN U52310CT2016PTC002136.
The company had an authorised share capital of ₹10 Lakh and a paid-up capital of ₹8 Lakh. It was led by directors Shaikh Firoj Hossien and Bhaskar Gupta.
Its last annual general meeting (AGM) was held on 30 September 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office was at L.I.G. – 101 Beside S.S.D. Ata Chakki Kavita Nagar, Raipur, Chhattisgarh, India – 492001.
As per the financials filed for FY 2017, the company reported a revenue of ₹3.68 Lakh. For the same year it recorded a net loss of ₹2.16 Lakh (net margin -58.8%) and EBITDA of ₹34,401 (EBITDA margin 9.4%).
Company details
Contact details
Lapis Lazuli Pharma Enterprises Private Limited's registered office is in Raipur, Chhattisgarh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressL.I.G. – 101 Beside S.S.D. Ata Chakki Kavita Nagar, Raipur, Chhattisgarh, India – 492001
- IndustryTrading, Wholesale, Other Wholesale
To see the full contact details of Lapis Lazuli Pharma Enterprises Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Lapis Lazuli Pharma Enterprises is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
Financials of Lapis Lazuli Pharma Enterprises Private Limited
FY 2019 filings availableLapis Lazuli Pharma Enterprises Private Limited reported revenue of ₹3.68 Lakh for FY 2017.
Financial Statement Summary
| Metrics | FY 2016-17 | FY 2015-16 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ₹3.68 Lakh | |
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ₹34,401 | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | -₹2.16 Lakh | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2016-17 | FY 2015-16 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 9.4% | |
| Net Profit Margin | -58.8% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Lapis Lazuli Pharma Enterprises Private Limited, buy the company report.
Board of directors of Lapis Lazuli Pharma Enterprises Private Limited
Lapis Lazuli Pharma Enterprises has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shaikh Firoj Hossien | Director | 30 Jun 2022 | 4 Years 4 Months | As last reported |
| Bhaskar Gupta Also directs: Tcp24 News Private Limited, BNN Multimedia Private Limited, Ecocomfort Solutions Private Limited and 2 more | Additional Director | 15 Feb 2020 | 6 Years 8 Months | As last reported |
Auditor
Lapis Lazuli Pharma Enterprises Private Limited is audited by SANJAYJHABAK&CO. for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SANJAYJHABAK&CO. | FY 2017 | 006877C |
Shareholding
The shareholding of Lapis Lazuli Pharma Enterprises Private Limited is on record for FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Lapis Lazuli Pharma Enterprises Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Lapis Lazuli Pharma Enterprises Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Lapis Lazuli Pharma Enterprises Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Lapis Lazuli Pharma Enterprises Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Lapis Lazuli Pharma Enterprises Private Limited has 6 board changes on record since 2019: 2 appointments and 4 cessations. The latest: Surendra Kumar Khatri ceased to be Additional Director on 01 Jul 2022.
Frequently asked questions
Lapis Lazuli Pharma Enterprises has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Lapis Lazuli Pharma Enterprises was a private limited company based in Raipur, Chhattisgarh, India. The company worked in wholesale, within the trading industry. It was incorporated on 16 February 2016 and is registered under CIN U52310CT2016PTC002136. The company has been struck off by the Registrar of Companies and is no longer operational.
Lapis Lazuli Pharma Enterprises had 2 directors:
- Shaikh Firoj Hossien - Director
- Bhaskar Gupta - Additional Director
The CIN (Corporate Identification Number) of Lapis Lazuli Pharma Enterprises is U52310CT2016PTC002136. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Lapis Lazuli Pharma Enterprises is at L.I.G. – 101 Beside S.S.D. Ata Chakki Kavita Nagar, Raipur, Chhattisgarh, India – 492001.
Lapis Lazuli Pharma Enterprises was incorporated on 16 February 2016. It is registered with the Registrar of Companies, Chhattisgarh.
The latest financial statements of Lapis Lazuli Pharma Enterprises on record with the MCA are for the year ended 31 March 2019. Its last annual general meeting was held on 30 September 2019. Year-wise statements from FY 2016 are in the company report.
Lapis Lazuli Pharma Enterprises operated in the trading industry, in the wholesale segment. It worked in this industry before it was struck off.
Surendra Kumar Khatri ceased to be Additional Director on 01 Jul 2022. Shaikh Firoj Hossien was appointed as Director on 30 Jun 2022. Shri Prakash Singh ceased to be Director on 17 Feb 2020. Lapis Lazuli Pharma Enterprises has 6 board changes on record in total.
The compliance status of Lapis Lazuli Pharma Enterprises is compliant as of 26 July 2026.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
